If testimony taken Nov. 14 in Kentucky, a major breeding and racing state, is any indication, the battle over use of furosemide on race day doesn’t figure to end any time soon.

With no regulatory action taken in any jurisdiction, even plans to ban the anti-bleeding medication called Salix, or Lasix, in certain graded stakes for 2-year-olds in 2012 seem up against it.

During a fact-finding meeting of the Kentucky Horse Racing Commission (KHRC) Race Day Medication Committee, formed to deal with furosemide and related adjunct bleeder medications, there were some unsubstantiated claims and discussion of research into furosemide–but even the science was interpreted in different ways. And disagreement continues over foreign countries in regard to drug-testing procedures and what therapeutic drugs they use in racehorses.

After five and a half hours of comment from various individuals and groups, it was clear no ground was broken on the issue and that more meetings will be held, at least in Kentucky